Interleukin (IL)-12 and IL-23 are key cytokines for immunity against salmonella in humans

Journal of Infectious Diseases

Volumn 190, Issue 10, 2004, Pages 1755-1757

  MacLennan, Calman ^a,j   Fieschi, Claire ^g   Lammas, David A ^a   Picard, Capucine ^g   Dorman, Susan E ^d   Sanal, Dzden ^f   MacLennan, Jenny M ^c   Holland, Steven M ^e   Dttenhoff, Tom H M ⁱ   Casanova, Jean Laurent ^g,h   Kumararatne, Dinakantha S ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f HACETTEPE UNIVERSITY   (Turkey)

^g IMAGINE INSTITUTE   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF MALAWI   (Malawi)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 23;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; HUMAN; IMMUNITY; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM; PRIORITY JOURNAL; SALMONELLA; SALMONELLOSIS; SEROTYPE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-23; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKINS; MALE; MIDDLE AGED; SALMONELLA; SALMONELLA INFECTIONS;

EID: 8444221890     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/425021     Document Type: Article

References (13)

1. Mastroeni P, Ugrinovic S, Chandra A, MacLennan C, Doffinger R, Kumararatne D. Resistance and susceptibility to Salmonella infections: lessons from mice and patients with immunodeficiencies. Rev Med Microbiol 2003; 14:53-62.
2. Eckmann L, Kagnoff ME. Cytokines in host defence against Salmonella. Microbes Infect 2001; 3:1191-200.
3. Jouany E, Doffinger R, Dupuis S, Pallier A, Altare F, Casanova JL. IL-12 and IFN-γ in host defence against mycobacteria and salmonella in mice and men. Curr Opin Immunol 1999; 11:346-51.
4. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002; 20:581-620.
5. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanisms of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 2003; 4:1230-7.
6. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3:133-46.
7. Lankford CS, Frucht DM. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003; 73:49-56.
8. Fieschi C, Dupuis S, Catherinot E, et al. Low penetrance, broad resistance and favorable outcome of IL-12 receptor β-deficiency: medical and immunological implications. J Exp Med 2003; 197:527-35.
9. Nakano Y, Onozuka K, Terada Y, Shinomiya H, Nakano M. Protective effect of recombinant TNF-α in murine salmonellosis. J Immunol 1990; 144:1935-41.
10. Morrissey PJ, Charrier K. GM-CSF administration augments the survival of ITY-resistant A/J mice, but not ITY-susceptible C57BL/6 mice, to a lethal challenge with Salmonella typhimurium. J Immunol 1990; 144:557-61.
11. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 2001; 345:1098-104.
12. Hubel K, Dale DC, Liles WC. Therapeutic use of cytokines to modulate phagocytic function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-γ. J Infect Dis 2002; 185:1490-501.
13. Fieschi C, Casanova JL. The role of interleukin-12 in human infectious diseases: only a faint signature. Eur J Immunol 2003; 33:1461-4.